MarketInOut Stock Screener Log In | Sign Up
 

Britannia Life Sciences Inc

CSE • Healthcare • Biotechnology • Quote as of 07/28/2026 09:54
Britannia Life Sciences Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeCSE
Market Capitalization11.36 mln
Earnings Date08/27/2025

EPS

0.06
Marginal

P / E

1.08
Deeply undervalued

Piotroski F-Score

6 / 9
Solid

Relative Strength

27 / 100
Underperforming

Debt / Equity

0.01
Debt-free

ROE

290
Extraordinary

Key Fundamentals

EPS0.06
P/E1.08
ROE290
RPS0.00
ROIC-17.22
ROA135
EBITDA, mln9.56
EV / EBITDA-0.36
EV / EBIT-0.37
Revenue, mln0.57
EV / Revenue-6.09

Financial Strength

Altman Z-Score3.48
Piotroski F-Score 6 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -7.14% 28 / 100   
1 Month -18.75% 38 / 100   
2 Months -40.91% 29 / 100   
6 Months -31.58% 45 / 100   
1 Year -18.75% 42 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us